CRMD cites diversified specialty pharma platform and new market opportunities
CRMD says it has evolved into a diversified specialty pharma with eight marketed products and a scalable institutional platform, citing reimbursement transition, Medicare Advantage focus, REZZAYO expansion potential, and robust financials for further growth.